Prevalence of Antiretroviral Drug Resistance Mutations Among Pretreatment and Antiretroviral Therapy-Failure HIV Patients in Uzbekistan. Mamatkulov A, Kazakova E, Ibadullaeva N, Joldasova E, Bayjanov A, Musabaev E, Kan N, Mustafaeva D, Lebedev A, Bobkova M, Kazennova E, Zohrabyan L (2020), AIDS Res Hum Retroviruses. 2020 Oct 8. doi: 10.1089/AID.2020.0096. Epub ahead of print. PMID: 32873061.

HIV-1 Sub-Subtype A6: Settings for Normalised Identification and Molecular Epidemiology in the Southern Federal District, Russia

Schlösser M, Kartashev VV, Mikkola VH, Shemshura A, Saukhat S, Kolpakov D, Suladze A, Tverdokhlebova T,
Hutt K, Heger E, Knops E, Böhm M, Di Cristanziano V, Kaiser R, Sönnerborg A, Zazzi M, Bobkova M and
Sierra S

Viruses 2020, 12, 475; doi:10.3390/v12040475

Analysis of the local HIV-1 epidemic in Vologda Region, Russia: predominance of CRF03_AB and rapid expansion of URFs

Ozhmegova E, Lebedev A, Krylova T, Kirillova I, Dementeva N, Kazennova E, Bobkova M. 

Poster presentation at 17th European AIDS Conference (EACS European AIDS Clinical Society, Basel, November 6-9, 2019). 

MiDRMpol: A High-Throughput Multiplexed Amplicon Sequencing Workflow to Quantify HIV-1 Drug Resistance Mutations against Protease, Reverse Transcriptase, and Integrase Inhibitors 

Shambhu G Aralaguppe, Anoop T Ambikan, Manickam Ashokkumar, Milner M Kumar, Luke Elizabeth Hanna, Wondwossen Amogne, Anders Sönnerborg, Ujjwal Neogi

Viruses 2019; 11: 806. 

doi:10.3390/v11090806

In vitro cross-resistance to doravirine in a panel of HIV-1 clones
harbouring multiple NNRTI resistance mutations. 

Saladini F, Giammarino F, Hosseini BA, Giannini A, Boccuto A,
Dragoni F, Vicenti I, Shafer RW and Zazzi M (2020), J Antimicrob Chemother, doi:10.1093/jac/dkaa401

Analysis of HIV-1 (Human immunodeficiency virus-1, Lentivirus, Orthoretrovirinae, Retroviridae) Nef protein polymorphism of variants circulating in the former USSR countries.

Gromov, K. & Kazennova, Elena & Kireev, Dmitry & Murzakova, A. & Lopatukhin, A. & Bobkova, M.

Problems of Virology 2019; 64(6)
DOI: https://doi.org/10.36233/0507-4088-2019-64-6-281-290

Comparable in vitro activity of second-generation HIV-1 integrase strand transfer inhibitors (INSTIs) on HIV-1 clinical isolates with INSTI resistance mutations

Saladini F, Giannini A, Boccuto A, Dragoni F, Appendino A, Albanesi E, Vicenti I, Zazzi M. 

Antimicrob Agents Chemother. 2019 Oct 14.  [Epub ahead of print]

doi: 10.1128/AAC.01717-19

pmid: 31611362

Transmitted drug resistance to NRTIs and risk of virological failure in naïve patients treated with integrase inhibitors. 

Borghetti, A., Ciccullo, A., Lombardi, F., Baldin, G., Belmonti, S., Prosperi, M., Incardona, F., Heger, E., Borghi, V., Sönnerborg, A., Zazzi, M., De Luca, A. and Di Giambenedetto, S. (2020), HIV Med. doi:10.1111/hiv.12956

Current trends in HIV genetic diversity in Russia: increased prevalence of unique recombinant variants

Antonova A, Lebedev A, KaBob E.

Poster presentation at 17th European AIDS Conference (EACS European AIDS Clinical Society, Basel, November 6-9, 2019). 

Molecular Surveillance of HIV-1 Infection in Krasnoyarsk Region, Russia: Epidemiology, Phylodynamics and Phylogeography

Neshumaev DLebedev AMalysheva MBoyko ASkudarnov SOzhmegova EAntonova AKazennova EBobkova M.

Curr HIV Res. 2019;17(2):114-125.

doi: 10.2174/1570162X17666190618155816.

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 825673.

Subscribe to the CARE newsletter
CONTACTS

Francesca Incardona

 

f.incardona@euresist.org